UTI India Innovation Fund
IE0001APTX67 · EUR Institutional Accumulating · EUR
▲ +19.3%
6M return
← Edit selection
Comparing 2 funds
Returns, costs and exposure side by side, with sources and dates below.
UTI India Sovereign Bond UCITS ETF
IE000LG8P349 · Class A USD Accumulating · USD
▲ +1.1%
6M return
Performance, starting at 100
GBP total return, daily prices to 21 Oct 2026. Source: FE fundinfo. Past performance is not a reliable guide to future returns.
If you had invested £10,000
What it would have become over 6M, GBP, month end to 30 Sep 2026.
Based on month end returns. Illustrative, before tax, not a prediction.
Country exposure
Average share of portfolio across these funds, as at 17 Oct 2026.
Not available for: UTI India Innovation Fund.
Sector exposure
Average share of portfolio across these funds, as at 17 Oct 2026.
AI comparison
AI assisted, not advice. Describes the data on this page.
Select Summarise differences for a short, neutral description of how these funds differ on the figures below.
Side by side
Returns in GBP, month end to 30 Sep 2026. Bold marks the highest value in the return rows, the lowest in the ongoing charge row and the largest in the fund size row.
| Metric | UTI India Innovation Fund | UTI India Sovereign Bond UCITS ETF |
|---|---|---|
| 1 year returnHighest in bold | ▼ −12.0% | ▼ −3.3% |
| 3 year returnHighest in bold | ▼ −14.7% | ▼ −4.6% |
| 5 year returnHighest in bold | n/a | n/a |
| Rank among sector peers, 1 yearQuartile among representative funds in the FE sector | Q4 of 539 representative funds | Q4 of 98 representative funds |
| Ongoing charge (OCF) | ||
| Fund size, GBPLargest in bold | £27.4M | £15.0M |
| Volatility, 1 year FE, as at 20 Jun 2026 | 25.1% | 6.6% |
| Sharpe ratio, 1 year FE, as at 20 Jun 2026 | -0.05 | -0.01 |
| Style | Active | Passive |
| FE sector | GL Equity India | GL Bond Government UD USD |
| Share class | EUR Institutional Accumulating · EUR | Class A USD Accumulating · USD |
Source: FE fundinfo, as supplied; the date shown is when FE last updated them.